Medicinal Plants in the Treatment of Myocardial Infarction Disease: A Systematic Review

Anamika Rathore1, Anuj Kumar Sharma1, Yogesh Murti2

  • 1Department of Pharmacology, Rajiv Academy for Pharmacy, Mathura, Uttar Pradesh, India.

PubMed

Insights

Herbal remedies show promise for treating myocardial infarction (MI). This review identified 140 plants, with flavonoids and glucosides being key compounds, highlighting natural substances for future MI treatments.

Area of Science:

  • Cardiovascular Medicine
  • Pharmacognosy
  • Phytochemistry

Background:

  • Myocardial infarction (MI), or heart attack, results from interrupted blood flow to the heart muscle.
  • MI can range from silent to life-threatening, causing hemodynamic instability and mortality.
  • Herbal remedies are increasingly recognized for their safety and accessibility in managing MI.

Purpose of the Study:

  • To review medicinal plants and phytochemicals used in myocardial infarction (MI) treatment.
  • To evaluate the potential of natural compounds in developing novel herbal MI therapies.

Main Methods:

  • A comprehensive literature search was conducted across major scientific databases.
  • Databases included Web of Science, Google Scholar, PubMed, Sci Finder, Reaxys, and Cochrane.

Main Results:

  • 140 plant species from 12 families were identified for their use in MI.
  • Data abstracted included plant families, parts used, chemical constituents, and dosages.
  • Fabaceae and Asteraceae were dominant families; flavonoids, glucosides, and alkaloids were prevalent compounds.

Conclusions:

  • Natural products, particularly flavonoids and glucosides, show significant potential for MI treatment.
  • This review provides a foundation for developing evidence-based herbal medicines for cardiovascular health.
Abstract

Related Concept Videos

Antianginal Drugs: Nitrates and β-Blockers01:16

Antianginal Drugs: Nitrates and β-Blockers

In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates,  such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
577
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
422
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
574
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.3K
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.8K